Roth/MKM analyst Jonathan Aschoff lowered the price target on Biofrontera (NASDAQ: BFRI) to $16.00 (from $25.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE